Manhattan Scientifics, Inc. (MHTX)

[eatbytes]

SSC,
The reason I'm so optimistic is that there's one big fundamental item that we've had too little of in the past. And that is that we've now got a valuable independent evaluator (MD Anderson Cancer Center) giving us what I believe is a solid recommendation of the future benefits of the MRX technology. This is a factor that has been noticeably lacking for the past upteem years. I'm now on the edge of my seat awaiting two additional independent cancer centers to provide me their analysis as well.